Skip to content

Dual Task Aerobic Exercise for Older Adults With Cognitive Impairment (HM2)

Study of Community Based Dual Task and Aerobic Exercise Intervention on Cognition and Mobility in Older Adults Without Dementia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01572311
Acronym
HM2
Enrollment
44
Registered
2012-04-06
Start date
2012-06-30
Completion date
2014-05-31
Last updated
2014-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment

Keywords

Aerobic exercise, Cognition, Dual Task, Gait Training, Group-based exercise, Older adults

Brief summary

The investigators proposed research will establish whether combining aerobic exercise with cognitive challenges is feasible and effective in community dwelling older adults with early signs of cognitive impairment.

Detailed description

To determine the effects of dual-task aerobic exercise training on community dwelling older adults with early signs of cognitive impairment. We will compare an exercise intervention (E-I) versus an exercise control (E-C) group. Each week, both groups will accumulate a minimum of 120 minutes of exercise (target 150 minutes) from community-based group classes (50 minutes of aerobic exercise) and also complete 45 minutes of beginner-level Square Stepping Exercise (SSE). The E-I group will also answer cognitively challenging questions while doing SSE (dual-task training). This study will determine whether a combined multiple modality (primary component being aerobic exercise) and dual-task exercise program is both feasible and effective for improving cognitive and mobility status, as well as vascular compliance, in older adults who may be at risk for cognitive and mobility decline.

Interventions

BEHAVIORALExercise Intervention

Goal of 150 minutes of structured exercise/week; minimum of 120 minutes from CCAA classes/week. The 75-minute class includes: 5-minute warm-up; 25 minutes of AE (70-85% maximum heart rate); 5-minute cool-down; 20 minutes of strength training; 5 minutes of core strengthening; 5 minutes of balance training; and 10 minutes of stretching. The 60-minute program is identical except: 15 minutes total for all strength training (including core) and 5 minutes of stretching. Following CCAA classes, participants continue with dual-task gait training where they are required to walk on a special mat with a designated walking pattern (beginner level Square Stepping Exercise) while answering cognitively challenging questions.

Goal of 150 minutes of structured exercise/week; minimum of 120 minutes from CCAA classes/week. The 75-minute class includes: 5-minute warm-up; 25 minutes of AE (70-85% maximum heart rate); 5-minute cool-down; 20 minutes of strength training; 5 minutes of core strengthening; 5 minutes of balance training; and 10 minutes of stretching. The 60-minute program is identical except: 15 minutes total for all strength training (including core) and 5 minutes of stretching. Following CCAA classes, participants continue with gait training where they are required to walk on a special mat with a designated walking pattern (beginner level Square Stepping Exercise). This will not include any dual-task challenges.

Sponsors

University of Western Ontario, Canada
CollaboratorOTHER
Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
Parkwood Hospital, London, Ontario
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
55 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Male/Female 55-90 years old. * Montreal Cognitive Assessment score ≤27 * Preserved Instrumental Activities of Daily Living (based on Lawton-Brody Instrumental Activities of Daily Living Sale)

Exclusion criteria

* Dementia (i.e., Mini-Mental Examination score \<24 or self-reported physician diagnosis) * Major Depression (\>=16 on the Center for Epidemiologic Studies - Depression Scale combined with clinical judgment by primary study physician) * Other neurological or psychiatric disorders * Recent history of severe cardiovascular conditions * Significant orthopedic conditions * Have blood pressure \>180/100 mmHg or \<100/60 mmHg * Unable to comprehend questionnaire material/study procedures

Design outcomes

Primary

MeasureTime frameDescription
Global cognitive functioning26 weeksFour standardized domain-specific composite scores were averaged to create this standardized global cognitive functioning score (incorporates executive function, processing speed, verbal learning and memory, and verbal fluency.

Secondary

MeasureTime frameDescription
Global cognitive functioning12 & 52 weeksFour standardized domain-specific composite scores were averaged to create this standardized global cognitive functioning score (incorporates executive function, processing speed, verbal learning and memory, and verbal fluency.
Executive Function/Mental Flexibility12, 26, and 52 weeksStandardized scores from seconds to complete Trail Making Test Part A and Trail Making Test Part B averaged to create this standardized composite score
Processing Speed12, 26 and 52 weeksStandardized score from the Digit-Symbol Substitution Test (total correct responses)
Verbal Learning and Memory12, 26 and 52 weeksStandardized scores from Auditory Verbal Learning Test (number of words learned and number of words recalled) were averaged to create this standardized composite score
Verbal Fluency12, 26 and 52 weeksStandardized scores from semantic (number of animals) and phonemic (number of words starting with C) were averaged to create this standardized composite score
Gait variability (step length) under dual-task conditions12, 26 and 52 weeksGait variability is the stride-to-stride fluctuations of the way someone walks and will be calculated as coefficient of variation of step length (SD/mean x 100). Measured with GAITRite system.
Gait variability (step length) under single-task conditions12, 26 and 52 weeksGait variability is the stride-to-stride fluctuations of the way someone walks and will be calculated as coefficient of variation of step length (SD/mean x 100). Measured with GAITRite system.
Gait speed under dual-task conditions12, 26 and 52 weeksAverage walking speed measured with GAITRite system
Gait speed under single-task conditions12, 26 and 52 weeksAverage walking speed measured with GAITRite system
Double support (seconds and % gait cycle time) under dual-task conditions12, 26 and 52 weeksInitial double support occurs from heel contact of one footfall to toe-off of the opposite footfall. Terminal double support occurs from opposite footfall heel strike to support footfall toe-off.Total double support is the sum of the initial double support added to the terminal double support. It is measured in seconds (sec) and also expressed as a percent of the Gait Cycle time for the same foot. Measured with GAITRite system
Double support (seconds and % gait cycle time) under single-task conditions12, 26 and 52 weeksInitial double support occurs from heel contact of one footfall to toe-off of the opposite footfall. Terminal double support occurs from opposite footfall heel strike to support footfall toe-off.Total double support is the sum of the initial double support added to the terminal double support. It is measured in seconds (sec) and also expressed as a percent of the Gait Cycle time for the same foot. Measured with GAITRite system
Step length under dual-task conditions12, 26 and 52 weeksMean step length measured with GAITRite system
Step length under single-task conditions12, 26 and 52 weeksMean step length measured with GAITRite system
Carotid artery compliance12, 26 and 52 weeksMeasured from non-invasive vascular assessment with B-mode Ultrasound over the carotid artery (in the neck)
Carotid artery Intima-media thickness (IMT)12, 26 and 52 weeksMeasured from non-invasive vascular assessment with B-mode Ultrasound over the carotid artery (in the neck)
Ambulatory systolic blood pressure12, 26 and 52 weeksAverage systolic blood pressure over a 24-hour time frame
Clinic systolic blood pressure12, 26 and 52 weeksAverage systolic blood pressure from final 2 (out of 3) readings
Ambulatory diastolic blood pressure12, 26 and 52 weeksAverage diastolic blood pressure over a 24-hour time frame
Clinic diastolic blood pressure12, 26 and 52 weeksAverage diastolic blood pressure from final 2 (out of 3) readings
Total balance score12, 26, and 52 weeksTotal balance score calculated from the Fullerton Advanced Balance Scale
Total Falls Self-Efficacy score12, 26, and 52 weeksTotal falls self-efficiacy score calculated from the Falls Self-Efficacy International (FES-I) scale

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026